A Healthy Volunteer Trial Investigating MR-enterography Image Quality of Lumentin® 44

Summary

A healthy volunteer, open, PoC single center trial investigating a new oral contrast agent for use in combination of MR examination of the abdomen and pelvis. The main purpose of the trial is to evaluate if Lumentin® 44 used as a bowel filling agent in MRE examination generates images with acceptable diagnostic quality. In addition, the plasma electrolytes concentration levels, including, potassium, sodium, phosphate, and calcium, as well as ionized calcium will be evaluated over a 24 hour time period after intake of Lumentin.

Timeline

Start

2023-01-15

Primary completion

2023-02-15

Completion

2023-02-28

Drugs

Indications

No indication recorded.